Instructions for use Alfazone

Hungary has approved a new potency booster - Alfazone capsules. The drug is available in the form of soft-shell capsules. The unique formula is based on natural ingredients from medicinal plants, which guarantees the safety of the product. Active substances have an accumulative property, therefore, in order to achieve the desired effect, the capsules should be taken according to the instructions.

How to use Alfazone

Alfazone are dissolvable capsules

For the treatment of erectile dysfunction, it is recommended to take one capsule in the morning and in the evening before or during meals, drinking plenty of clean water without gas. The duration of treatment can be 30 days, depending on the form and severity of erectile dysfunction. In order to prevent the drug can last 10-15 days, one capsule per day. To stimulate an erection before sexual intimacy, you should drink two capsules 15-20 minutes before the planned act.

Indications for use of Alfazone capsules:

The reasons for the development of erectile dysfunction and decreased libido can be different, but there are a number of signs that can determine the presence of a problem. The indications for taking Alfazone are:

  • weak attraction or lack thereof;
  • disappearance of morning or nocturnal erections;
  • too long an interval between the start of intercourse and the onset of an erection;
  • difficulty in achieving orgasm, the pleasure itself is moderately expressed;
  • premature ejaculation;
  • decrease in the amount of sperm excreted;
  • the impossibility of a repeated act after a short rest;
  • the erection comes quickly, but disappears before the act;
  • total helplessness.

Contraindications of Alfazone capsules

Not recommended for people under 18 (only after puberty). Although clinical trials did not reveal allergic reactions, people with individual intolerance to one of the components of the composition (damian, ginseng or zinc) should better refrain from using the capsules. In addition, they cannot be used in the presence of oncological diseases of the genitourinary system.